Cellectar Biosciences (CLRB) — AI Analysis & Mentions

Cellectar Biosciences is receiving bullish signals from its own management, with both the CEO and COO making notable open-market stock and warrant purchases. This kind of insider buying demonstrates confidence in the company's future, a positive sign for long-term, value-oriented investors. The warrants were also purchased at the current market price, indicating optimism about upcoming milestones.